By addressing translational challenges and tackling off-target toxicities, the 2nd ADC Toxicity Summit is returning at an imperative time to allow you to prevent, predict and mitigate toxicities ...
MedPage Today on MSN2d
Investigational ADC Shows Promise in Advanced Endometrial CancerPuxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...
In a high-stakes move set to reshape the biotech landscape, Taiho Pharmaceutical Co. Ltd. announced Monday that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback